Drug Landscape ›
Photodynamic Therapy ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 124
Most-reported reactions
Wrong Technique In Product Usage Process — 39 reports (31.45%) Erythema — 19 reports (15.32%) Drug Ineffective — 15 reports (12.1%) Product Complaint — 11 reports (8.87%) Pain — 10 reports (8.06%) Nonspecific Reaction — 8 reports (6.45%) Off Label Use — 6 reports (4.84%) Skin Exfoliation — 6 reports (4.84%) Application Site Pain — 5 reports (4.03%) Application Site Reaction — 5 reports (4.03%)
Source database →
Photodynamic Therapy in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Photodynamic Therapy approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Photodynamic Therapy in United States?
Roswell Park Cancer Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.